Bank Of New York Mellon Corp Homology Medicines, Inc. Transaction History

Bank Of New York Mellon Corp

$521 Trillion
Q1 2024

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 09, 2023	BUY	$0.91 - $1.69 $17,684 - $32,843	19,434 New	19,434 $20 Million
Q4 2022 Feb 14, 2023	BUY	$1.09 - $2.04 $21,183 - $39,645	19,434 New	19,434 $24,000
Q2 2022 Aug 15, 2022	SELL	$1.39 - $3.12 $188,718 - $423,599	-135,769 Reduced 87.48%	19,434 $38,000
Q1 2022 May 11, 2022	SELL	$2.6 - $4.17 $13,868 - $22,242	-5,334 Reduced 3.32%	155,203 $472,000
Q4 2021 Feb 11, 2022	BUY	$3.64 - $7.78 $56,001 - $119,695	15,385 Added 10.6%	160,537 $584,000

Q3 2021 Nov 12, 2021	BUY	$6.01 - $8.71 $72,222 - $104,668	12,017 Added 9.03%	145,152 $1.14 Million
Q2 2021 Aug 11, 2021	BUY	$6.02 - $9.64 $87,362 - $139,895	14,512 Added 12.23%	133,135 $0
Q1 2021 May 13, 2021	SELL	$9.17 - $14.8 $13,021 - $21,016	-1,420 Reduced 1.18%	118,623 $0
Q4 2020 Feb 09, 2021	BUY	$8.92 - $13.29 $31,532 - $46,980	3,535 Added 3.03%	120,043 $0
Q3 2020 Nov 12, 2020	SELL	$9.94 - $16.59 $5,089 - $8,494	-512 Reduced 0.44%	116,508 $0
Q2 2020 Aug 12, 2020	BUY	$12.07 - $19.34 $338,454 - $542,312	28,041 Added 31.51%	117,020 $0
Q1 2020 May 06, 2020	SELL	$12.5 - $22.04 $53,437 - $94,221	-4,275 Reduced 4.58%	88,979 $0
Q4 2019 Feb 14, 2020	BUY	$11.42 - $22.19 $37,035 - $71,962	3,243 Added 3.6%	93,254 $0
Q3 2019 Nov 07, 2019	BUY	$14.74 - $22.28 $47,168 - $71,296	3,200 Added 3.69%	90,011 $0
Q2 2019 Aug 12, 2019	BUY	$18.35 - $30.34 $444,914 - $735,623	24,246 Added 38.75%	86,811 $1.7 Million
Q1 2019 May 14, 2019	BUY	$19.76 - $29.57 $79,790 - $119,403	4,038 Added 6.9%	62,565 $1.74 Million
Q4 2018 Feb 11, 2019	BUY	$18.39 - $26.3 $573,400 - $820,034	31,180 Added 114.02%	58,527 $1.31 Million
Q2 2018 Aug 06, 2018	BUY	$16.49 - $21.55 $450,952 - $589,327	27,347 New	27,347 $558,000

Others Institutions Holding FIXX

# of Institutions

Shares Held

66.2K

Call Options Held

Put Options Held

View Full List

About Homology Medicines, Inc.

Ticker FIXX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 57,402,000
Description
Homology Medicines, Inc., a genetic medicines company, focuses on transforming the lives of patients suffering from rare genetic diseases. Its proprietary platform is designed to utilize its human hematopoietic stem cell derived adeno-associated virus vectors (AAVHSCs) to deliver genetic medicines in vivo either through a gene therapy or nucleas...

More about FIXX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of New York Mellon Corp, based on Form 13F filings with the SEC.

News

Stay updated on Bank Of New York Mellon Corp with notifications on news.

Account